The protein has a predicted molecular mass of 18.1 kDa after removal of the signal peptide.
Conjugate
Unconjugated
Purity
> 95%, by SDS-PAGE and Coomassie blue staining.
Product Form
Lyophilized
Concentration
Reconstitution dependent.
Formulation
Lyophilized from sterile Phosphate Buffered Saline, pH 7.4. Normally 5%–8% Trehalose is added as a protectant before lyophilization.
Storage
Shipped at 4°C. Lyophilized: Store at -20°C to -80°C. Reconstituted: Aliquot and store at -80°C. Product is stable for one year. Avoid freeze/thaw cycles.
Recombinant Human TNF alpha Protein (6xHis Tag) (A318337)
ELISA plates were pre-coated with Recombinant Human TNF alpha Protein (6×His Tag) (A318337) at 2 µg/ml (100 µl/well) which can bind Certolizumab Biosimilar - Anti-TNF alpha Antibody - BSA and Azide free (A324624) in a linear range of 0.64–16 ng/ml.
Recombinant Human TNF alpha Protein (6xHis Tag) (A318337)
ELISA plates were pre-coated with Recombinant Human TNF alpha Protein (6×His Tag) (A318337) at 2 µg/ml (100 µl/well) which can bind Golimumab Biosimilar - Anti-TNF alpha Antibody - BSA and Azide free (A324668) in a linear range of 3.20–80 ng/ml.
Recombinant Human TNF alpha Protein (6xHis Tag) (A318337)
ELISA plates were pre-coated with Recombinant Human TNF alpha Protein (6×His Tag) (A318337) at 1 µg/ml (100 µl/well) which can bind Adalimumab Biomsimilar - Anti-TNF alpha Antibody - BSA and Azide free (A318901) in a linear range of 0.64-16 ng/ml.
